Clinical Trial: Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962371) titled 'Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)' on April 03.

Brief Summary: The purpose of this study is to assess the feasibility and safety of the Transverse Medical, Inc. Point-Guard device. This feasibility study is a limited clinical investigation of the Point-Guard device. The study will be conducted to evaluate the device design concept with respect to clinical safety and device functionality.

Study Start Date: April 07

Study Type: INTERVENTIONAL

Condition: Transcatheter Aortic Valve Implantation (TAVI) Aortic Valve Stenosis Transcatheter Aortic Valve Replacement

I...